Submission Details
| 510(k) Number | K853278 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 05, 1985 |
| Decision Date | November 07, 1985 |
| Days to Decision | 94 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | — |
K853278 is an FDA 510(k) clearance for the POLIO TYPE I CF ANTIGEN, & TYPE II, III, a Antisera, Cf, Poliovirus 1-3 (Class I — General Controls, product code GOG), submitted by Hillcrest Biologicals (Cypress, US). The FDA issued a Cleared decision on November 7, 1985, 94 days after receiving the submission on August 5, 1985. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3405.
| 510(k) Number | K853278 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 05, 1985 |
| Decision Date | November 07, 1985 |
| Days to Decision | 94 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | — |
| Product Code | GOG — Antisera, Cf, Poliovirus 1-3 |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3405 |